| 1. |
中華醫學會呼吸分會睡眠呼吸障礙學組, 中國醫學裝備協會呼吸病學裝備技術專業委員會睡眠呼吸設備學組. 成人阻塞性睡眠呼吸暫停高危人群篩查與管理專家共識. 中華健康管理學雜志, 2022, 16(8): 520-528.
|
| 2. |
程建琴, 趙丹, 張湘燕. 阻塞性睡眠呼吸暫停低通氣綜合征的流行病學及臨床研究進展. 中國呼吸與危重癥監護雜志, 2023, 22(12): 899-903.
|
| 3. |
Klemen ND, Feingold PL, Hashimoto B, et al. Mortality risk associated with venous thromboembolism: a systematic review and Bayesian meta-analysis. Lancet Haematol, 2020, 7(8): e583-e593.
|
| 4. |
Timp JF, Braekkan SK, Versteeg HH, et al. Epidemiology of cancer-associated venous thrombosis. Blood, 2013, 122(10): 1712-23.
|
| 5. |
Mao LR, Jiménez D, Bikdeli B, et al. Prognostic impact of obstructive sleep apnea in pations presenting with acute symptomatic pulmonary embolism. Thromb Haemost, 2021, 121(6): 808-815.
|
| 6. |
Yamashita Y, Morimoto T, Amano H, et al. Validation of simplified PESI score for identification of low-risk patients with pulmonary embolism: From the COMMAND VTE Registry. Eur Heart J Acute Cardiovasc Care, 2020, 9(4): 262-270.
|
| 7. |
Heit, JA. The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol, 2008, 28(3): 370-372.
|
| 8. |
Jiménez D, de Miguel-Díez J, Guijarro R, et al. Trends in the management and outcomes of acute pulmonary embolism: analysis from the RIETE registry. J Am Coll Cardiol, 2016, 67(2): 162-170.
|
| 9. |
Benjafield AV, AYAS NT, EASTWOOD PR, et al. Estimation of the global prevalence and burden of obstuctive sleep apnoea: a literature-based analysis. Lancet Respir Med, 2019, 7(8): 687-698.
|
| 10. |
Heinzer R, Vat S, Marques-Vidal P, et al. Prevalence of sleep-disordered breathing in the general population: the HypnoLaus study. Lancet Respir Med, 2015, 3(4): 310-318.
|
| 11. |
Motamedi V, Kanefsky R, Matsangas P, et al. Elevated tau and interleukin-6 concentrations in adults with obstructive sleep apnea. Sleep Med, 2018, 43: 71-76.
|
| 12. |
Peng YH, Liao WC, Chung WS, et al. Association between obstructive sleep apnea and deep vein thrombosis/pulmonary embolism: a population-based retrospective cohort study. Thromb Res, 2014, 134(2): 340-345.
|
| 13. |
Alonso-Fernández A, dela Pe?a M, Romero D, et al. Association between obstructive sleep apnea and pulmonary embolism. Mayo Clinic Proc, 2013, 38(6): 579-587.
|
| 14. |
呂琴, 何雅, 高慎敏. 肺栓塞患者合并阻塞性睡眠呼吸暫停發病率及危險因素Meta分析. 四川醫學, 2023, 44(4): 349-355.
|
| 15. |
沈品良. 肺血栓栓塞癥合并阻塞性睡眠呼吸暫停綜合征的臨床特征. 烏魯木齊, 新疆醫科大學, 2019.
|
| 16. |
Konnerth D, Schwarz F, Probst M, et al. Is acute pulmonary embolism more severe in the presence of obstructive sleep apnea? Results from an observational cohort study. J Thromb Thrombolysis, 2018, 46(2): 253-259.
|
| 17. |
Joshi AA, Hajjali RH, Gokhale AV, et al. Outcomes of patients hospitalized for acute pulmonary embolism by obstructive sleep apnea status. Pulm Circ, 2021, 11(2): 1-9.
|
| 18. |
Chen J, Cao Y, Li, Z, et al. Association between the severity of obstructive sleep apnea and the risk stratification of acute pulmonary embolism. Clin Appl Thromb Hemost, 2023, 29: 110760296231175654.
|
| 19. |
中華醫學會呼吸病學分會肺栓塞與肺血管病學, 中國醫師協會呼吸醫師分會肺栓塞與肺血管病工作委員會. 全國肺栓塞與肺血管病防治協作組. 肺血栓栓塞癥診治與預防指南. 中華醫學雜志, 2018, 98(14): 1060-1087.
|
| 20. |
杭燕萍, 趙明明, 張希龍. 阻塞性睡眠呼吸暫停綜合征與肺血栓栓塞癥. 內科理論與實踐, 2019, 14(4): 265-268.
|
| 21. |
Floras JS. Sympathetic nervous system in patients with sleep related breathing disorders. Curr Hypertens Rev, 2016, 12(1): 18-26.
|
| 22. |
尚粉青, 郭瑄, 顧興. 阻塞性睡眠呼吸暫停低通氣綜合征患者血清miRNA-92a水平與血管內皮功能損傷的關系研究. 中國呼吸與危重監護雜志. 2021, 20(9): 625-631.
|
| 23. |
Rajachandran M, Nickel N, Lange RA. sleep apnea and cardio-vascula risk. Curr Opin Cardiol, 2023, 38(5): 456-461.
|
| 24. |
Atkeson A, Jelic, S. Mechanisms of endothelial dysfunction in obstructive sleep apnea. Vasc Health Risk Manag, 2008, 4(6): 1327-1335.
|
| 25. |
Al Mutairi S, Mojiminiyi OA, Al Alawi A, et al. Study of leptin and adiponectin as disease markers in subjects with obstructive sleep apnea. Dis Markers, 2014, 2014: 706314.
|
| 26. |
Hou N, Luo JD. Leptin and cardiovascular diseases. Clin Exp Pharmacol Physiol, 2011, 38(12): 905-913.
|
| 27. |
鄭曙光, 郭香香, 姚麗琴. 急性肺栓塞合并阻塞性睡眠呼吸暫停低通氣綜合征患者血清D-二聚體N末端腦鈉肽前體肌鈣蛋白水平研究. 中國藥物與臨床, 2020, 20(8): 1325-1327.
|
| 28. |
García Suquia A, Alonso-Fernández A, de la Pe?a M, et al. High D-dimer levels after stopping anticoagulants in pulmonary embolism with sleep apnoea. Eur Respir, 2015, 46(6): 1691-1700.
|
| 29. |
Geissenberger F, Schwarz F, Probst M, et al. Obstructive sleep apnea is associated with pulmonary artery thrombus load, disease severity, and survival in acute pulmonary embolism. Clin Res Cardiol, 2020, 109(1): 13-21.
|
| 30. |
Xu J, Wang X, Meng F, et al. The role of obstructive sleep apnea on the prognosis of pulmonary embolism: a systemic review and meta-analysis. Sleep Breath, 2021, 25(3): 1419-1426.
|
| 31. |
Barbero E, Ma?as E, Bikdeli B, et al. Untreated obstructive sleep apnea and cardiovascular outcomes in patients with acute symptomatic pulmonary embolism. Thromb Res, 2022, 214: 87-92.
|
| 32. |
Seckin ZI, Helmi H, Weister TJ, et al. Acute pulmonary embolism in patients with obstructive sleep apnea: frequency, hospital outcomes, and recurrence. J Clin Sleep Med, 2020, 16(7): 1029-1036.
|
| 33. |
Xie J, Wei YX, Liu S, et al. Obstructive sleep apnea hypopnea syndrome as a reason for active management of pulmonary embolism. Chin Med J(Engl), 2015, 128(16): 2147-2153.
|
| 34. |
Steffanina A, Proietti L, Antonaglia C, et al. The plasminogen system and transforming growth factor-β in subjects with obstructive sleep apnea syndrome: effects of CPAP treatment. Respir Care, 2015, 60(11): 1643-1651.
|
| 35. |
陳晨. 探討阻塞性睡眠呼吸暫停低通氣綜合征與肺栓塞的病理機制及預后策略. 世界睡眠醫學雜志, 2021, 8(10): 1839-1840.
|
1/5
WeChat